MINNEAPOLIS, July 27 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI) announced today that it will release financial results for the first fiscal quarter ended June 30, 2009, at the market close on Monday, August 3, 2009. The Company will host a conference call to discuss these results on Monday, August 3, 2009 at 3:30 p.m. Central Time. David Kaysen, President and Chief Executive Officer, and Medi Jiwani, Vice President, Chief Financial Officer and Treasurer, will host the call. Individuals wishing to participate in the conference call should dial 877-941-1466 (domestic) or 480-629-9644 (international). An audio replay will be available for 30 days following the call at 800-406-7325 (domestic) or 303-590-3030 (international), with the passcode 4119644 #.
About Uroplasty, Inc.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our primary focus is on sales growth in the U.S. market. We offer the Urgent PC((R)) system, which we believe is the only FDA-approved minimally invasive nerve stimulation device designed for office-based treatment of urinary urgency, urinary frequency and urge incontinence - symptoms often associated with overactive bladder. We also offer Macroplastique((R)) Implants, an injectable bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Please visit Uroplasty, Inc. at www.uroplasty.com.
For Further Information:
Uroplasty, Inc. EVC Group
------------------------------------- ---------
David Kaysen, President and CEO, or Doug Sherk/(Investors)
Medi Jiwani, Vice President, CFO, and 415.896.6820
Treasurer,
952.426.6140 Chris Gale/Steve DiMattia (Media)
646.201.5431
SOURCE Uroplasty, Inc.
